GlassScriptPhysician profile
Roblyn Skibinski
NPI 1356959670
$3,236.60
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $573 · 2022: $1,742 · 2023: $671 · 2024: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $733.12 | 2021-2024 | Spravato |
| Novartis Pharmaceuticals Corporation | $302.30 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.30 | 2022 | |
| Novo Nordisk INC | $213.56 | 2022 | |
| Astellas Pharma US INC | $212.15 | 2021 | |
| Inspire Medical Systems, INC. | $175.55 | 2023 | Inspire |
| Amgen INC. | $154.91 | 2022-2023 | Prolia |
| Abbvie INC. | $125.00 | 2023 | |
| Urovant Sciences INC | $124.99 | 2022 | |
| Idorsia Pharmaceuticals US INC | $124.99 | 2023 | Quviviq |
| Horizon Therapeutics Plc | $123.42 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $123.32 | 2022 | |
| Sage Therapeutics, LLC | $111.91 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $92.49 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.34 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $69.47 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $60.82 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $53.48 | 2021-2023 | Farxiga |
| Abiomed | $31.19 | 2022 | |
| Merck Sharp & Dohme LLC | $27.90 | 2021 | |
| Terumo Medical Corporation | $21.48 | 2023 | Navicross, Metacross Otw, Azur Cx Detachable |
| Impulse Dynamics (USA) INC. | $16.28 | 2022 | |
| Lundbeck LLC | $14.31 | 2021 | |
| Pfizer INC. | $14.21 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roblyn Skibinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.